Post Operative Urinary Retention (POUR) Following Thoracic Oncological Surgery
ConditionUrinary Retention
Trial statusRecruiting
Trial phaseEarly Phase 1
Trial typeInterventional
Biological sexMale
Age55+
SponsorHackensack Meridian Health
About this trial
This is a feasibility study looking at whether the use of Tamsulosin could lower the high incidence of postoperative urinary retention (POUR) in older men who undergo an oncological thoracic surgical procedure for suspected or confirmed cancer. In addition, the study will try to identify the time of resumption of presurgical urinary function post Tamsulosin administration.
Eligibility criteria
Qualifiers
Males
≥55 years old
Planned thoracic oncological surgical procedure of a video assisted oncological surgical procedure for suspected or confirmed cancer.
Surgery scheduled more than 7 days from the time of consent
Disqualifiers
Using Tamsulosin already
Known allergy to Tamsulosin or sulfa drugs
Current use of Boceprevir
Resting systolic blood pressure <100
Trial design
Treatments tested in this trial
- Tamsulosin
Treatment groups
46 Participants
are divided into 1 treatment groupLocations
4Ocean University Medical Center08724, BrickNew Jersey, United States
South Ocean University Medical Center08050, ManahawkinNew Jersey, United States
Jersey Shore University Medical Center07753, Neptune CityNew Jersey, United States
Riverview Medical Center07701, Red BankNew Jersey, United States
Sponsors and collaborators
Hackensack Meridian Health
Lead sponsor
Source ClinicalTrials.gov